Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications

Maurizio Bruschi, Giovanni Candiano, Leopoldo Della Ciana, Andrea Petretto, Laura Santucci, Marco Prunotto, Roberta Camilla, Rosanna Coppo, Gian Marco Ghiggeri

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Reactive oxygen species (ROS) are potentially implicated in renal pathology. Direct evidence is available for animal models of glomerulonephritis but the demonstration of ROS implication in human diseases is only circumstantial and requires further experimental support. One problem limiting any evolution is the brief life of ROS (in terms of milliseconds) that makes it difficult their direct detection 'in vivo'. An alternative is to look at the products of oxidation of proteins that remain in blood as a signature of ROS activity. Recent data have shown the presence of oxidation products of albumin (sulfonic 34Cys albumin) in serum of patients with focal-glomerulosclerosis, that is a primary glomerular diseases causing nephrotic syndrome. Structural studies based on spectroscopy and calorimetry strengthened the relevance of oxidation of the unique free SH groups of 34Cys for conformation of albumin, in analogy with what already reported for other proteins. In this review, we present new developments on technologies for the detection of the oxido-redox potential of proteins that are based on the concept that oxidation is inversely correlated with their free content of sulphydryl groups. We describe, in particular, two new iodoacetamide-substituted cyanines that have been developed for labelling sulphydryl groups and can be utilized as stable dyes prior mono- and bi-dimensional electrophoresis. Proteins with low binding with iodoacetamide-cyanines may be considered as surrogate biomarkers of ROS activity. Standardization of these techniques and their acquisition in more laboratories would enable clinicians to plan screening studies on ROS in human diseases.

Original languageEnglish
Pages (from-to)1338-1344
Number of pages7
JournalJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Volume879
Issue number17-18
DOIs
Publication statusPublished - May 15 2011

Fingerprint

Oxidation-Reduction
Blood Proteins
Reactive Oxygen Species
Technology
Iodoacetamide
Albumins
Oxidation
Proteins
Focal Segmental Glomerulosclerosis
Calorimetry
Nephrotic Syndrome
Biomarkers
Pathology
Glomerulonephritis
Electrophoresis
Serum Albumin
Labeling
Standardization
Conformations
Spectrum Analysis

Keywords

  • Focal segmental glomerulosclerosis
  • Glomerulonephritis
  • Reactive oxygen species
  • Serum albumin
  • Sulphydryl groups

ASJC Scopus subject areas

  • Biochemistry
  • Analytical Chemistry
  • Cell Biology
  • Clinical Biochemistry

Cite this

Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications. / Bruschi, Maurizio; Candiano, Giovanni; Ciana, Leopoldo Della; Petretto, Andrea; Santucci, Laura; Prunotto, Marco; Camilla, Roberta; Coppo, Rosanna; Ghiggeri, Gian Marco.

In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 879, No. 17-18, 15.05.2011, p. 1338-1344.

Research output: Contribution to journalArticle

@article{7cb55ea9888a4ad6ad14e1d706ace9ae,
title = "Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications",
abstract = "Reactive oxygen species (ROS) are potentially implicated in renal pathology. Direct evidence is available for animal models of glomerulonephritis but the demonstration of ROS implication in human diseases is only circumstantial and requires further experimental support. One problem limiting any evolution is the brief life of ROS (in terms of milliseconds) that makes it difficult their direct detection 'in vivo'. An alternative is to look at the products of oxidation of proteins that remain in blood as a signature of ROS activity. Recent data have shown the presence of oxidation products of albumin (sulfonic 34Cys albumin) in serum of patients with focal-glomerulosclerosis, that is a primary glomerular diseases causing nephrotic syndrome. Structural studies based on spectroscopy and calorimetry strengthened the relevance of oxidation of the unique free SH groups of 34Cys for conformation of albumin, in analogy with what already reported for other proteins. In this review, we present new developments on technologies for the detection of the oxido-redox potential of proteins that are based on the concept that oxidation is inversely correlated with their free content of sulphydryl groups. We describe, in particular, two new iodoacetamide-substituted cyanines that have been developed for labelling sulphydryl groups and can be utilized as stable dyes prior mono- and bi-dimensional electrophoresis. Proteins with low binding with iodoacetamide-cyanines may be considered as surrogate biomarkers of ROS activity. Standardization of these techniques and their acquisition in more laboratories would enable clinicians to plan screening studies on ROS in human diseases.",
keywords = "Focal segmental glomerulosclerosis, Glomerulonephritis, Reactive oxygen species, Serum albumin, Sulphydryl groups",
author = "Maurizio Bruschi and Giovanni Candiano and Ciana, {Leopoldo Della} and Andrea Petretto and Laura Santucci and Marco Prunotto and Roberta Camilla and Rosanna Coppo and Ghiggeri, {Gian Marco}",
year = "2011",
month = "5",
day = "15",
doi = "10.1016/j.jchromb.2010.11.030",
language = "English",
volume = "879",
pages = "1338--1344",
journal = "Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences",
issn = "1570-0232",
publisher = "Elsevier",
number = "17-18",

}

TY - JOUR

T1 - Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications

AU - Bruschi, Maurizio

AU - Candiano, Giovanni

AU - Ciana, Leopoldo Della

AU - Petretto, Andrea

AU - Santucci, Laura

AU - Prunotto, Marco

AU - Camilla, Roberta

AU - Coppo, Rosanna

AU - Ghiggeri, Gian Marco

PY - 2011/5/15

Y1 - 2011/5/15

N2 - Reactive oxygen species (ROS) are potentially implicated in renal pathology. Direct evidence is available for animal models of glomerulonephritis but the demonstration of ROS implication in human diseases is only circumstantial and requires further experimental support. One problem limiting any evolution is the brief life of ROS (in terms of milliseconds) that makes it difficult their direct detection 'in vivo'. An alternative is to look at the products of oxidation of proteins that remain in blood as a signature of ROS activity. Recent data have shown the presence of oxidation products of albumin (sulfonic 34Cys albumin) in serum of patients with focal-glomerulosclerosis, that is a primary glomerular diseases causing nephrotic syndrome. Structural studies based on spectroscopy and calorimetry strengthened the relevance of oxidation of the unique free SH groups of 34Cys for conformation of albumin, in analogy with what already reported for other proteins. In this review, we present new developments on technologies for the detection of the oxido-redox potential of proteins that are based on the concept that oxidation is inversely correlated with their free content of sulphydryl groups. We describe, in particular, two new iodoacetamide-substituted cyanines that have been developed for labelling sulphydryl groups and can be utilized as stable dyes prior mono- and bi-dimensional electrophoresis. Proteins with low binding with iodoacetamide-cyanines may be considered as surrogate biomarkers of ROS activity. Standardization of these techniques and their acquisition in more laboratories would enable clinicians to plan screening studies on ROS in human diseases.

AB - Reactive oxygen species (ROS) are potentially implicated in renal pathology. Direct evidence is available for animal models of glomerulonephritis but the demonstration of ROS implication in human diseases is only circumstantial and requires further experimental support. One problem limiting any evolution is the brief life of ROS (in terms of milliseconds) that makes it difficult their direct detection 'in vivo'. An alternative is to look at the products of oxidation of proteins that remain in blood as a signature of ROS activity. Recent data have shown the presence of oxidation products of albumin (sulfonic 34Cys albumin) in serum of patients with focal-glomerulosclerosis, that is a primary glomerular diseases causing nephrotic syndrome. Structural studies based on spectroscopy and calorimetry strengthened the relevance of oxidation of the unique free SH groups of 34Cys for conformation of albumin, in analogy with what already reported for other proteins. In this review, we present new developments on technologies for the detection of the oxido-redox potential of proteins that are based on the concept that oxidation is inversely correlated with their free content of sulphydryl groups. We describe, in particular, two new iodoacetamide-substituted cyanines that have been developed for labelling sulphydryl groups and can be utilized as stable dyes prior mono- and bi-dimensional electrophoresis. Proteins with low binding with iodoacetamide-cyanines may be considered as surrogate biomarkers of ROS activity. Standardization of these techniques and their acquisition in more laboratories would enable clinicians to plan screening studies on ROS in human diseases.

KW - Focal segmental glomerulosclerosis

KW - Glomerulonephritis

KW - Reactive oxygen species

KW - Serum albumin

KW - Sulphydryl groups

UR - http://www.scopus.com/inward/record.url?scp=79955621123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955621123&partnerID=8YFLogxK

U2 - 10.1016/j.jchromb.2010.11.030

DO - 10.1016/j.jchromb.2010.11.030

M3 - Article

C2 - 21185243

AN - SCOPUS:79955621123

VL - 879

SP - 1338

EP - 1344

JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

SN - 1570-0232

IS - 17-18

ER -